r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and AL Amyloidosis

r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid has been researched along with AL Amyloidosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barton, SV; Berges, AC; Cookson, LM; Fontana, M; Gillmore, JD; Hawkins, PN; Lane, T; Moon, JC; Pepys, MB; Pinzani, M; Richards, DB; Ritter, JM	1

Trials

1 trial(s) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and AL Amyloidosis

Article	Year
Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component. The New England journal of medicine, 2015, Sep-17, Volume: 373, Issue:12 Topics: Adult; Aged; Amyloidosis; Antibodies, Monoclonal; Carboxylic Acids; Dose-Response Relationship, Drug; Humans; Immunoglobulin G; Immunoglobulin Light-chain Amyloidosis; Infusions, Intravenous; Liver; Middle Aged; Pyrrolidines; Radionuclide Imaging; Serum Amyloid P-Component	2015

Article

Year

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.

The New England journal of medicine, 2015, Sep-17, Volume: 373, Issue:12

Topics: Adult; Aged; Amyloidosis; Antibodies, Monoclonal; Carboxylic Acids; Dose-Response Relationship, Drug; Humans; Immunoglobulin G; Immunoglobulin Light-chain Amyloidosis; Infusions, Intravenous; Liver; Middle Aged; Pyrrolidines; Radionuclide Imaging; Serum Amyloid P-Component

2015